RBM19 and hepatocellular carcinoma: The immunohistochemistry (IHC) results demonstrated that DYNC1H1, GTPBP4, PRKDC, RBM19, SF3B4, SPATS2 and TAF9 were significantly increased in HCC tumor cells compared to normal hepatocytes (Figures 9, 10).